Sampling solutions

You are here

Colli-Pee standardized first-void urine collection.

Colli-Pee is a patented, award-winning, CE-labelled & FDA-listed device to efficiently and hygienically capture first-void urine (first catch of the urine flow; first 20ml). Colli-Pee is a user-friendly and compact device which is suited for postal delivery. It can be used by all genders. 

Collection of first-void urine allows for improved detection of:

  • Biomarkers for early stage diagnosis and monitoring of (urological) cancers.
  • Sexually transmitted infections (STIs) like Chlamydia, Gonorrhea, Mycoplasma, Trichomonas, and Zikavirus.
  • Human Papilloma Virus (HPV), a virus able to cause cervical cancer.

 

How it works
What we do

Find out more!

Colli-Pee

Aim: Use of self-sampling devices for detection of HPV

Partners: IPH Belgium, University of Antwerp, Abbott, Roche, BD, Cepheid, Seegene, Fujirebio, Novosanis

Study design:

A total of 500 women, referral population will be included through colposcopy clinics in Belgium (Tienen, Brussels, Ghent and Antwerp). Women will be asked to collect different self-samplers, including Evalyn® brush or Qvintip (50-50), Colli-Pee™ FV-5000 series (UCM preservative), and FLOQSwab™. Additionally a clinician-based sample will be taken.

Assays: COBAS4800 & 6800 (Roche) & Anyplex (Seegene) & Innolipa (Fujirebio) & Onclarity (BD)µ

Status: Inclusions ongoing

Self-samples and clinician-based samples will be analyzed for the presence of HPV.

Application areas

Regulatory
Posters & Publications